Stock Updates

Incyte Corporation (NASDAQ: INCY) – Is this large market cap stock undervalued?

Incyte Corporation (NASDAQ: INCY), is firmly in the large market cap category with market cap of 17521.6. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Incyte Corporation is 93.2 (with a change from open of -1.87%), this in conjunction with a target price of 98.71. Volume today has so far reached 2646900, with an average volume of about 1155.85. The GAP for this stock, is 6.64%.

The P/E ratio is 274.93, bringing the forward P/E to a value of 68.38. The current EPS for Incyte Corporation, is 0.34, with a EPS growth for this year coming to a value of 112.10%. Performance has been interesting with performance year to date coming to -14.06%.

Looking further into the growth statistics for Incyte Corporation, EPS is looking like it will grow 640.76% in the next year. Looking even further it is projected to be 55.39%. Quarter over quarter is 257.80% for EPS growth and for sales growth quarter over quarter it is 51.10%. Looking at past EPS growth statistics we see that for the past five years it has been 16.40%. Sales growth for the past five years has in fact been 34.70%.

Looking at the ownership, we see that the insider ownership is at 0.50% and institutional ownership is 97.10%. Shares outstanding is 188, while shares float is at a value of 186.94. Float short for Incyte Corporation is 2.72% and the short ratio is 4.39.

In terms of debt, long term debt/equity is 2.14, while the total debt/equity comes to 0. The ability to meet these debts, means that the current ratio is 4, and the quick ratio is 4. The most recent gross margin is 96.20% and their operating margin is 15.50%. The profit margin is 7.90%.

Incyte Corporation has seen returns on assets of 6.60%, and on investment, 6.30%. Return on equity is 37.80%. Price/Earnings to growth ratio is 4.96. Price/Sales ratio is at a value of 18.62, with Price/book ratio coming to 58.99 and Price/cash is 27.85, and finally Price/Free cash Flow is 206.62.

The simple moving averages are 11.02% and 15.19% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -29.03% and the 52 week low is 69.45%.

Incyte Corporation has a dividend yield of *TBA, with a current price of 93.2. The ability to pay this means the payout ratio is 0.00%. This is in an industry, Biotechnology, with equally high dividends from other companies in this sector, which it is Healthcare. Incyte Corporation is based in USA.

Performance in the Biotechnology industry means that Incyte Corporation has seen performance for the past week of 7.48%, with performance for the month coming to 14.59%. Looking at the data for the quarter it is at a value of 18.36%, and for the half year the performance is -6.42%. Volatility for this week is 3.24% and for the month this is 3.10%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment